Atherogenous dyslipidemia and liver

Authors

  • O. M. Drapkina Clinic for Propedeutics of Internal Diseases, Gastroenterology and Hepatology. V.Kh. Vasilenko Moscow Medical Academy. I. M. Sechenova
  • E. L. Bueverova Clinic for Propedeutics of Internal Diseases, Gastroenterology and Hepatology. V.Kh. Vasilenko of the Moscow Medical Academy. I. M. Sechenova
  • V. T. Ivashkin Clinic for Propedeutics of Internal Diseases, Gastroenterology and Hepatology. V.Kh. Vasilenko of the Moscow Medical Academy. I. M. Sechenova

Keywords:

atherogenous dyslipidemia, non-alhogolic fatty liver disease, statins

Abstract

Cardiovascular diseases are the main causes of disability and mortality. Atherogenic dyslipidemia is the main
risk factor of the cardiovascular problems. Liver takes part in the change of the cholesterol. It is known, that the
atherogenous dyslipidemia in majority of such patients is combined to non-alhogolic fatty liver disease. (20-
80%). Necessity and safety of application of statins in patients with non-alhogolic fatty liver disease is discussed
in the article

Downloads

Download data is not yet available.

Downloads

Published

2010-12-15

How to Cite

Drapkina O. M., Bueverova E. L., Ivashkin V. T. Atherogenous dyslipidemia and liver // The Journal of Atherosclerosis and Dyslipidemias. 2010. VOL. № 1(1). PP. 25–31.

Issue

No. 1(1) (2010)

Section

Original research paper